Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries” report has been added to ResearchAndMarkets.com’s offering.

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. The researchers analysis indicates that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $66 billion by 2022, with a CAGR of 23.3% between this time frame.

Scope of the Report

An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies. Global regenerative medicine market, global breakdown, application breakdown and leading market players Detailed account of the stem cell industry market by geography, indication and company profiles Profiles, marketed/pipeline products, financial analysis and business strategy of the major companies in this space Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for regenerative medicine Insight into the challenges faced by stakeholders, particularly about the success vs. failure ratios in developing regenerative medicine drugs and therapies. Insight into the biobanking industry globally and its impact on the overall market Description and data for the prevalence of disease types that are addressed by regenerative medicine, stem cells, tissue engineering and CAR-T therapies Financial market forecast through 2022 with CAGR values of all market segments outlined in the objective SWOT analysis of the global market Geographical analysis and challenges within key topographies including the USA, Japan, South Korea, China and Europe

Key Topics Covered:

1.0 Report Synopsis

2.0 Introduction

3.0 Stem Cells and Clinical Trials

4.0 Stem Cells, Disruptive Technology, Drug Discovery & Toxicity Testing

5.0 Stem Cell Biomarkers

6.0 Manufacturing Stem Cell Products

7.0 Investment & Funding

8.0 Regenerative Medicine Market Analysis & Forecast to 2022

9.0 Stem Cell Market Analysis & Forecast to 2022

10.0 Tissue Engineering Tissue Engineering Market Analysis and Forecast to 2022

11.0 Biobanking Market Analysis

12.0 Global Access & Challenges of the Regenerative Medicine Market

13.0 Cell and CAR T Therapy

14.0 Company Profiles

15.0 SWOT Industry Analysis

Companies Mentioned

Astellas Institute for Regenerative Medicine (Ocata Therapeutics) AstraZeneca Athersys Baxter International (Baxalta, Shire) Bayer Caladrius Biosciences (NeoStem) Celgene CHA Biotech Chimerix Cynata Therapeutics Cytori Therapeutics Eisai Genzyme (Sanofi) GSK Janssen InCyte Corp MedImmune MEDIPOST Merck Mesoblast Millennium Pharmaceutical NuVasive Osiris Therapeutics Plasticell Pluristem Therapeutics Pfizer SanBio Current Stem Cell Trials Seattle Genetics Current Stem Cell Trials StemCells Inc STEMCELL Technologies Takara Bio Teva Current Stem Cell Trials Tigenix

For more information about this report visit https://www.researchandmarkets.com/research/qjkhdg/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612005760/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs,Biopharmaceuticals,Stem Cells,Biomaterials



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 07:13 AM/DISC: 06/12/2018 07:13 AM


Update hourly